Structures by: Bhadbhade M. M.
Total: 149
Hexa-O-benzoyl-myo-inositol
C48H36O12
Chemical Communications (2004) 22 2530-2531
a=13.9840(7)Å b=13.9840(7)Å c=36.504(3)Å
α=90.00° β=90.00° γ=120.00°
Hexa-O-benzoyl-myo-inositol
C48H36O12
Chemical Communications (2004) 22 2530-2531
a=11.931(3)Å b=14.463(4)Å c=14.722(4)Å
α=64.109(4)° β=71.642(5)° γ=67.851(6)°
Hexa-O-benzoyl-myo-inositol
C48H36O12,1.75(CH2Cl2),0.25(H2O)
Chemical Communications (2004) 22 2530-2531
a=13.961(2)Å b=14.214(2)Å c=15.134(2)Å
α=104.827(2)° β=101.516(2)° γ=117.970(2)°
Myo-inositol
C48.5H39BrO13S
Chemical Communications (2001) 10 881
a=26.9267(17)Å b=11.7160(8)Å c=30.874(2)Å
α=90.00° β=105.9980(10)° γ=90.00°
Myo-inositol
C48.25H38.50Cl0.50O13S
Chemical Communications (2001) 10 881
a=26.771(4)Å b=11.608(3)Å c=30.783(6)Å
α=90.00° β=105.176(6)° γ=90.00°
C20H22O2
C20H22O2
CrystEngComm (2011) 13, 9 3162
a=5.977(2)Å b=17.481(6)Å c=14.845(5)Å
α=90.00° β=93.708(6)° γ=90.00°
C21H26O3
C21H26O3
CrystEngComm (2011) 13, 9 3162
a=10.9252(11)Å b=12.8444(11)Å c=12.9669(13)Å
α=81.473(4)° β=85.560(4)° γ=82.793(4)°
C28H32O2
C28H32O2
CrystEngComm (2011) 13, 9 3162
a=21.82(6)Å b=6.006(18)Å c=34.11(10)Å
α=90.00° β=95.12(18)° γ=90.00°
C23H25O2
C23H25O2
CrystEngComm (2011) 13, 9 3162
a=29.898(2)Å b=6.0728(3)Å c=20.9859(12)Å
α=90.00° β=110.252(3)° γ=90.00°
4-O-TOSYL 2,6-O-DIACETYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C18H20O10S
CrystEngComm (2009) 11, 6 1022
a=16.4270(17)Å b=6.1377(6)Å c=19.2741(19)Å
α=90.00° β=91.317(2)° γ=90.00°
6-O-TOSYL 2,4-O-DIACETYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C18H20O10S
CrystEngComm (2009) 11, 6 1022
a=6.206(2)Å b=14.602(5)Å c=42.099(13)Å
α=90.00° β=90.00° γ=90.00°
6-O-TOSYL 4,2-DI-O-ACETYL MYO-INOSITOL ORTHOACETATE
C19H22O10S
CrystEngComm (2009) 11, 6 1022
a=6.2596(8)Å b=9.8947(12)Å c=17.022(2)Å
α=87.723(2)° β=89.460(2)° γ=76.195(2)°
6-O-TOSYL 4,2-DI-O-ACETYL MYO-INOSITOL ORTHOACETATE
C19H22O10S
CrystEngComm (2009) 11, 6 1022
a=9.2713(11)Å b=35.728(4)Å c=6.1772(8)Å
α=90.00° β=90.872(2)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Cl2O8
CrystEngComm (2008) 10, 3 288
a=6.794(5)Å b=11.545(9)Å c=13.565(10)Å
α=106.843(11)° β=98.733(12)° γ=91.059(12)°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Br2O8
CrystEngComm (2008) 10, 3 288
a=6.825(3)Å b=8.330(4)Å c=18.181(9)Å
α=80.744(9)° β=88.609(9)° γ=83.038(10)°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Cl2O8
CrystEngComm (2008) 10, 3 288
a=6.815(3)Å b=8.325(3)Å c=17.887(7)Å
α=80.140(7)° β=87.493(8)° γ=83.024(8)°
C20H23O10
C20H23O10
CrystEngComm (2012) 14, 1 138
a=11.0883(5)Å b=8.5689(3)Å c=21.5332(9)Å
α=90.00° β=93.1040(10)° γ=90.00°
C16H18O10
C16H18O10
CrystEngComm (2012) 14, 1 138
a=7.2550(2)Å b=9.2807(3)Å c=13.0344(4)Å
α=77.3590(10)° β=78.8160(10)° γ=88.8110(10)°
C19H23.5O10.5
C19H23.5O10.5
CrystEngComm (2012) 14, 1 138
a=11.3769(5)Å b=8.3198(4)Å c=21.4511(10)Å
α=90.00° β=98.021(3)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,CH3NO2,0.25(H2O)
CrystEngComm (2012) 14, 5 1716
a=12.401(4)Å b=12.587(4)Å c=13.250(4)Å
α=98.697(5)° β=108.729(5)° γ=117.919(4)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,CH2Cl2
CrystEngComm (2012) 14, 5 1716
a=13.463(2)Å b=14.451(3)Å c=17.848(3)Å
α=90.00° β=91.363(3)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,C2H4cl2
CrystEngComm (2012) 14, 5 1716
a=13.39(2)Å b=14.35(3)Å c=17.54(3)Å
α=90.00° β=91.55(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,0.25(CH2Cl2)
CrystEngComm (2012) 14, 5 1716
a=11.499(5)Å b=11.793(5)Å c=12.374(5)Å
α=94.564(7)° β=101.799(7)° γ=105.126(7)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,C2H3N,0.5(H2O)
CrystEngComm (2012) 14, 5 1716
a=12.404(4)Å b=12.492(4)Å c=13.331(4)Å
α=99.188(5)° β=109.620(5)° γ=116.837(4)°
1,2,3,4(6),5-O-PENTA ACETYL 6(4)-O-CAMPHORSULFONYL MYO-INOSITOL
C26H36O14S,0.75(C3H6O)
CrystEngComm (2012) 14, 5 1716
a=13.597(4)Å b=14.351(4)Å c=17.818(5)Å
α=90.00° β=91.466(5)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,0.75(CHCl3)
CrystEngComm (2012) 14, 5 1716
a=13.857(3)Å b=14.298(3)Å c=17.717(4)Å
α=90.00° β=90.651(4)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate
C21H16Br2O8
CrystEngComm (2008) 10, 3 288
a=6.8481(14)Å b=11.662(2)Å c=13.675(3)Å
α=107.123(4)° β=99.175(4)° γ=90.909(3)°
C25H15.5Br4N2.5S
C25H15.5Br4N2.5S
CrystEngComm (2015) 17, 47 9111
a=9.1820(18)Å b=9.6642(19)Å c=14.466(3)Å
α=83.296(4)° β=75.723(4)° γ=73.399(4)°
C25H15.5Br4N2.5S
C25H15.5Br4N2.5S
CrystEngComm (2015) 17, 47 9111
a=8.1907(13)Å b=9.4970(15)Å c=15.261(2)Å
α=90.457(3)° β=96.073(4)° γ=98.192(3)°
C25H15.5Br4N2.5S
C25H15.5Br4N2.5S
CrystEngComm (2015) 17, 47 9111
a=7.7119(10)Å b=10.6252(15)Å c=15.117(2)Å
α=98.268(3)° β=99.550(3)° γ=101.403(3)°
C22H12Br4N2S,C9H12
C22H12Br4N2S,C9H12
CrystEngComm (2015) 17, 47 9111
a=10.592(4)Å b=11.235(5)Å c=13.182(7)Å
α=93.99(3)° β=102.12(2)° γ=108.62(2)°
C22H12Br4N2S,0.5(C10H20)
C22H12Br4N2S,0.5(C10H20)
CrystEngComm (2015) 17, 47 9111
a=9.488(4)Å b=10.506(6)Å c=13.679(8)Å
α=88.73(4)° β=76.54(4)° γ=78.50(4)°
C60H42Fe2N12O3S6,4(C2H3N),4(BF4),0.5(H2O)
C60H42Fe2N12O3S6,4(C2H3N),4(BF4),0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 8 2543-2548
a=11.724(2)Å b=15.555(3)Å c=21.641(4)Å
α=89.79(3)° β=85.72(3)° γ=73.09(3)°
C60H42Fe2N12O3S6,2(C2H3N),4(BF4),0.25(O)
C60H42Fe2N12O3S6,2(C2H3N),4(BF4),0.25(O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 8 2543-2548
a=11.806(2)Å b=15.605(3)Å c=22.029(4)Å
α=89.52(3)° β=85.48(3)° γ=73.49(3)°
C27H35ClN6O10Rh
C27H35ClN6O10Rh
Journal of the Chemical Society, Dalton Transactions (1999) 12 2009
a=9.072(4)Å b=11.749(3)Å c=16.605(5)Å
α=75.09(2)° β=77.14(3)° γ=89.52(3)°
C24H23.6N6O7.8Rh
C24H23.6N6O7.8Rh
Journal of the Chemical Society, Dalton Transactions (1999) 12 2009
a=23.410(4)Å b=16.013(7)Å c=15.006(8)Å
α=90.00° β=108.23(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dimethyl sulphoxide solvate
C21H16Cl2O8,C2H6OS
CrystEngComm (2010) 12, 12 4184
a=12.9731(13)Å b=10.2342(11)Å c=18.0469(19)Å
α=90.00° β=102.585(2)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dioxane solvate
C21H16Cl2O8,C4H8O2
CrystEngComm (2010) 12, 12 4184
a=13.047(3)Å b=10.141(3)Å c=18.678(5)Å
α=90.00° β=103.518(4)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate p- xylene solvate
C21H16Cl2O8,0.5(C8H10)
CrystEngComm (2010) 12, 12 4184
a=11.6917(18)Å b=9.6018(15)Å c=21.103(3)Å
α=90.00° β=94.329(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate 1,2- dichloroethane solvate
C21H16Cl2O8,C2H4Cl2
CrystEngComm (2010) 12, 12 4184
a=12.093(2)Å b=9.9108(17)Å c=20.260(3)Å
α=90.00° β=92.433(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate acetonitrile solvate
C21H16Cl2O8,C2H3N
CrystEngComm (2010) 12, 12 4184
a=12.074(10)Å b=9.861(8)Å c=20.003(16)Å
α=90.00° β=94.894(13)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate benzene solvate
C21H16Cl2O8,0.5(C6H6)2
CrystEngComm (2010) 12, 12 4184
a=32.22(3)Å b=9.584(8)Å c=21.386(19)Å
α=90.00° β=129.72(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Cl2O8,0.06(CH2Cl2)
CrystEngComm (2010) 12, 12 4184
a=12.962(2)Å b=10.1406(17)Å c=18.391(3)Å
α=90.00° β=102.627(3)° γ=90.00°
Hexa-O-toluoyl-myo-inositol
C54H48O12
CrystEngComm (2010) 12, 2 478
a=12.130(5)Å b=30.223(11)Å c=14.383(5)Å
α=90.00° β=110.068(7)° γ=90.00°
C35H23Cl2N2
C35H23Cl2N2
CrystEngComm (2015) 17, 4 877
a=21.2603(17)Å b=42.109(4)Å c=5.7891(5)Å
α=90.00° β=90.00° γ=90.00°
C36H28Cl2N2O
C36H28Cl2N2O
CrystEngComm (2015) 17, 4 877
a=10.3943(5)Å b=17.4818(10)Å c=15.6814(8)Å
α=90.00° β=97.6860(10)° γ=90.00°
C37H28Cl2N2O2
C37H28Cl2N2O2
CrystEngComm (2015) 17, 4 877
a=10.4620(5)Å b=17.5011(8)Å c=15.8272(8)Å
α=90.00° β=95.5300(10)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate chloroform solvate
C21H16Br2O8,CHCl3
CrystEngComm (2010) 12, 12 4184
a=12.8141(17)Å b=10.2601(14)Å c=18.756(3)Å
α=90.00° β=102.832(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate acetone solvate
C21H16Br2O8,C3H6O
CrystEngComm (2010) 12, 12 4184
a=12.8133(15)Å b=10.2045(12)Å c=18.814(2)Å
α=90.00° β=103.599(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Br2O8,CH2Cl2
CrystEngComm (2010) 12, 12 4184
a=12.8524(11)Å b=10.2018(8)Å c=18.5250(15)Å
α=90.00° β=102.8700(10)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate nitromethane solvate
C21H16Br2O8,CH3NO2
CrystEngComm (2010) 12, 12 4184
a=12.1747(15)Å b=10.1533(12)Å c=19.261(2)Å
α=90.00° β=103.231(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dioxane solvate
C21H16Br2O8,C4H8O2
CrystEngComm (2010) 12, 12 4184
a=13.1856(16)Å b=10.2483(13)Å c=18.966(2)Å
α=90.00° β=104.704(2)° γ=90.00°
2,6-di-O-p-bromobenzoyl-myo-inositol 1,3,5-orthoformate dimethyl sulphoxide solvate
C21H16Br2O8,C2H6OS
CrystEngComm (2010) 12, 12 4184
a=13.0322(15)Å b=10.2499(11)Å c=18.415(2)Å
α=90.00° β=103.579(2)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate chloroform solvate
C21H16Cl2O8,CHCl3
CrystEngComm (2010) 12, 12 4184
a=12.9486(9)Å b=10.2705(7)Å c=18.0529(12)Å
α=90.00° β=101.3980(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate acetone solvate
C21H16Cl2O8,C3H6O
CrystEngComm (2010) 12, 12 4184
a=12.751(2)Å b=10.2210(18)Å c=18.520(3)Å
α=90.00° β=103.209(3)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate dichloromethane solvate
C21H16Cl2O8,CH2Cl2
CrystEngComm (2010) 12, 12 4184
a=12.8921(11)Å b=10.1356(9)Å c=18.0788(16)Å
α=90.00° β=101.5840(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate nitromethane solvate
C21H16Cl2O8,CH3NO2
CrystEngComm (2010) 12, 12 4184
a=12.6835(7)Å b=10.0712(5)Å c=18.2980(10)Å
α=90.00° β=103.1000(10)° γ=90.00°
2,6-di-O-p-chlorobenzoyl-myo-inositol 1,3,5-orthoformate tetrahydrofuran solvate
C21H16Cl2O8,C4H8O
CrystEngComm (2010) 12, 12 4184
a=12.908(3)Å b=10.135(2)Å c=18.299(4)Å
α=90.00° β=101.682(4)° γ=90.00°
C16H18O10,0.25(C4H8O)
C16H18O10,0.25(C4H8O)
Acta Crystallographica Section B (2014) 70, 1 126-131
a=11.2247(4)Å b=8.3660(3)Å c=21.5073(8)Å
α=90° β=97.265(2)° γ=90°
C16H18O10,0.5(C4H8O)
C16H18O10,0.5(C4H8O)
Acta Crystallographica Section B (2014) 70, 1 126-131
a=11.4634(8)Å b=8.5336(7)Å c=21.6678(16)Å
α=90° β=99.580(2)° γ=90°
(4<i>R</i>,5<i>S</i>,6<i>R</i>)-6-Azido-5-benzyloxy-3,3,4-trifluoroazepan-1-ium 2,2,2-trifluoroacetate
C13H16F3N4O,C2F3O2
Acta Crystallographica Section E (2015) 71, 11 1361-1365
a=5.8780(12)Å b=34.503(7)Å c=8.8120(18)Å
α=90° β=92.42(3)° γ=90°
Poly[[μ~3~-(<i>S</i>)-2-amino-3-hydroxypropanoato]-<i>cis</i>-di-μ-chlorido-caesiumpalladium(II)]
C3H6Cl2CsNO3Pd
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1898-1902
a=11.594(4)Å b=17.072(5)Å c=4.4739(12)Å
α=90° β=90° γ=90°
C10H14Cl2N2O8Ru1,K1
C10H14Cl2N2O8Ru1,K1
Acta Crystallographica Section C (1992) 48, 7 1202-1204
a=10.4470(6)Å b=13.947(2)Å c=11.296(3)Å
α=90° β=106.100(10)° γ=90°
C18H26CuN4O8
C18H26CuN4O8
Acta Crystallographica Section C (1997) 53, 4 422-425
a=10.613(2)Å b=15.402(3)Å c=12.928(4)Å
α=90.00° β=93.35(3)° γ=90.00°
C8H24CuN6O6
C8H24CuN6O6
Acta Crystallographica Section C (1995) 51, 10 2016-2018
a=10.099(3)Å b=15.040(4)Å c=9.917(2)Å
α=90° β=98.05(2)° γ=90°
C12H24N6O6Ru1,2(Cl1)
C12H24N6O6Ru1,2(Cl1)
Acta Crystallographica Section C (1992) 48, 8 1402-1405
a=13.4890(5)Å b=9.6913(7)Å c=16.6847(5)Å
α=90° β=112.365(3)° γ=90°
Cu(C6H8N2)2(BF4)2
Cu(C6H8N2)2(BF4)2
Acta Crystallographica Section C (1996) 52, 12 3049-3051
a=7.974(2)Å b=21.692(4)Å c=10.038(7)Å
α=90.00° β=90.00° γ=90.00°
C41H35N3P2Ru
C41H35N3P2Ru
Acta Crystallographica Section C (1994) 50, 4 502-504
a=11.969(3)Å b=14.5410(10)Å c=11.2840(10)Å
α=111.510(10)° β=110.690(10)° γ=88.27(2)°
C13H14CuN2O6
C13H14CuN2O6
Acta Crystallographica Section C (1997) 53, 2 193-195
a=7.138(3)Å b=10.148(4)Å c=10.686(2)Å
α=105.81(3)° β=104.54(2)° γ=105.30(3)°
5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]diazepin-11(10<i>H</i>)-one
C13H10N2O
Acta Crystallographica Section C (2012) 68, 6 o240-o246
a=7.4767(16)Å b=10.861(2)Å c=12.475(2)Å
α=90.00° β=98.277(6)° γ=90.00°
1-(11-hydroxy-5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]diazepin-5-yl)-2- {4-[3-(1<i>H</i>-imidazol-1-yl)propyl]piperidin-1-yl}ethanone ethanol monosolvate
C26H29N5O2,C2H6O
Acta Crystallographica Section C (2012) 68, 6 o240-o246
a=8.7319(8)Å b=16.0343(16)Å c=19.2802(18)Å
α=93.029(5)° β=95.427(5)° γ=93.662(5)°
4,6-di-O-benzyl-myo-inositol 1,3,5-orthoformate
C21H22O6
Acta Crystallographica Section C (2005) 61, 11 o628-o630
a=9.0511(11)Å b=10.0953(12)Å c=10.6586(13)Å
α=68.849(2)° β=81.453(2)° γ=87.433(2)°
4,6-di-<i>O</i>-acetyl-2-<i>O</i>-tosyl-<i>myo</i>-inositol 1,3,5-orthoformate
C18H20O10S
Acta Crystallographica Section C (2009) 65, 7 o335-o338
a=8.5756(6)Å b=11.0381(8)Å c=11.2005(8)Å
α=100.4260(10)° β=103.1230(10)° γ=99.6600(10)°
4,6-di-<i>O</i>-acetyl-2-<i>O</i>-tosyl-<i>myo</i>-inositol 1,3,5-orthobenzoate
C24H24O10S
Acta Crystallographica Section C (2009) 65, 7 o335-o338
a=12.3019(14)Å b=8.2155(10)Å c=23.551(3)Å
α=90.00° β=91.306(2)° γ=90.00°
2,4(6)-di-O-benzoyl-6(4)-O-{[(1S)-7,7-dimethyl-2- oxobicyclo[2.2.1]heptan-1-ylmethyl]sulfonyl}-myo-inositol 1,3,5-orthoacetate
C32H34O11S
Acta Crystallographica Section C (2007) 63, 9 o555-o558
a=11.5241(16)Å b=11.6958(16)Å c=12.453(2)Å
α=80.499(3)° β=62.449(2)° γ=75.937(2)°
6-<i>O</i>-acryloyl-2-<i>O</i>-benzoyl-<i>myo</i>-inositol 1,3,5-orthoformate
C17H16O8
Acta Crystallographica Section C (2009) 65, 2 o54-o57
a=8.8808(6)Å b=9.5502(6)Å c=9.7100(6)Å
α=102.2660(10)° β=101.7330(10)° γ=94.3340(10)°
6-<i>O</i>-acryloyl-2-<i>O</i>-benzoyl-<i>myo</i>-inositol 1,3,5-orthoformate
C17H16O8
Acta Crystallographica Section C (2009) 65, 2 o54-o57
a=13.813(4)Å b=19.279(5)Å c=5.9801(15)Å
α=90.00° β=96.665(4)° γ=90.00°
7α,15α-Dibromo-8,16-diphenyl-6,7,14,15-tetrahydro-6α,14α- epithiocycloocta[1,2-<i>b</i>:5,6-<i>b</i>]diquinoline deuterochloroform solvate
C34H22Br2N2S,CDCl3
Acta Crystallographica Section E (2009) 65, 9 o2253
a=10.161(4)Å b=10.246(5)Å c=15.868(6)Å
α=93.88(3)° β=99.43(3)° γ=92.50(3)°
(3<i>R</i>,4<i>S</i>,5<i>S</i>,8<i>S</i>,10<i>R</i>,13<i>R</i>)- 3-Hydroxykaura-9(11),16-dien-18-oic acid
C20H28O3
Acta Crystallographica Section E (2012) 68, 2 o526-o527
a=8.064(2)Å b=10.775(3)Å c=10.462(4)Å
α=90.00° β=109.70(2)° γ=90.00°
C27H26N4O4
C27H26N4O4
Langmuir : the ACS journal of surfaces and colloids (2016) 32, 9 2245-2250
a=5.0100(10)Å b=17.384(4)Å c=13.250(3)Å
α=90° β=91.32(3)° γ=90°
1, 1'-Bis[4-(5-bromouracyl)n-butyl] ferrocene
C26H28Br2FeN4O4
Journal of Organic Chemistry (2008) 73, 1508-1515
a=14.408(4)Å b=14.455(4)Å c=13.137(4)Å
α=90.00° β=90.00° γ=90.00°
1, 1'-Bis[4-(thyminyl)n-butyl]ferrocene
C28H34FeN4O4
Journal of Organic Chemistry (2008) 73, 1508-1515
a=14.074(5)Å b=14.676(5)Å c=13.252(5)Å
α=90.00° β=90.00° γ=90.00°
C19H22FeN2O2
C19H22FeN2O2
Journal of Organic Chemistry (2008) 73, 1508-1515
a=7.588(3)Å b=9.813(5)Å c=12.300(6)Å
α=67.192(7)° β=89.527(8)° γ=86.364(8)°
1, 1'-Bis[4-(uracyl)n-butyl] ferrocene
C26H30FeN4O4
Journal of Organic Chemistry (2008) 73, 1508-1515
a=8.403(3)Å b=9.705(4)Å c=16.496(6)Å
α=98.201(7)° β=92.759(7)° γ=111.989(7)°
1-(4-(Thyminyl)butyl)-1'-(4-(uracyl)butyl)ferrocene
C27H31FeN4O4
Journal of Organic Chemistry (2008) 73, 1508-1515
a=13.675(3)Å b=14.687(3)Å c=13.361(3)Å
α=90.00° β=90.00° γ=90.00°
C18H20FeN2O2
C18H20FeN2O2
Journal of Organic Chemistry (2008) 73, 1508-1515
a=7.376(2)Å b=9.785(3)Å c=11.757(3)Å
α=108.301(5)° β=94.061(6)° γ=91.481(6)°
C19H27NO9
C19H27NO9
Journal of Organic Chemistry (2005) 70, 8579-8582
a=6.8229(8)Å b=15.4730(17)Å c=18.734(2)Å
α=90.00° β=90.00° γ=90.00°
C22H22FeN4O4,O0.48,2.07(O)
C22H22FeN4O4,O0.48,2.07(O)
Journal of Organic Chemistry (2010) 75, 8705-8708
a=11.529(5)Å b=12.016(5)Å c=16.731(7)Å
α=90.00° β=109.697(7)° γ=90.00°
C20H18FeN4O4
C20H18FeN4O4
Journal of Organic Chemistry (2010) 75, 8705-8708
a=12.917(10)Å b=6.740(5)Å c=25.088(16)Å
α=90.00° β=119.87(3)° γ=90.00°
C29H56P4Ru
C29H56P4Ru
Organometallics (2010) 29, 4 957
a=10.109(2)Å b=13.500(3)Å c=13.660(3)Å
α=77.70(3)° β=72.79(3)° γ=68.84(3)°
C28H46P4Ru
C28H46P4Ru
Organometallics (2010) 29, 4 957
a=9.6302(18)Å b=12.118(2)Å c=26.325(5)Å
α=90.00° β=91.897(7)° γ=90.00°
C23H43P4Ru
C23H43P4Ru
Organometallics (2010) 29, 4 957
a=9.0216(8)Å b=9.1604(7)Å c=17.2534(15)Å
α=96.199(4)° β=92.234(3)° γ=104.126(4)°
C43H41Cl2P3Ru,2(C6H6)
C43H41Cl2P3Ru,2(C6H6)
Organometallics (2011) 30, 23 6433
a=15.501(3)Å b=16.367(3)Å c=17.976(3)Å
α=90.00° β=90.00° γ=90.00°
C48H52NP3Ru
C48H52NP3Ru
Organometallics (2011) 30, 23 6433
a=10.9740(4)Å b=20.8634(8)Å c=18.2687(7)Å
α=90.00° β=91.7040(10)° γ=90.00°
C48H50ClNP3Ru,C24H20B,C3H6O
C48H50ClNP3Ru,C24H20B,C3H6O
Organometallics (2011) 30, 23 6433
a=13.7351(12)Å b=15.1183(6)Å c=17.0756(7)Å
α=115.483(2)° β=99.362(3)° γ=90.794(2)°
6(4)-O-CAMPHORSULFONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S
Crystal Growth & Design (2005) 5, 3 833
a=14.115(3)Å b=11.592(3)Å c=17.743(4)Å
α=90.00° β=92.529(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.375(CH2Cl2)
Crystal Growth & Design (2005) 5, 3 833
a=30.561(17)Å b=10.925(6)Å c=22.255(12)Å
α=90.00° β=114.922(10)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.75(C6H6)
Crystal Growth & Design (2005) 5, 3 833
a=31.182(4)Å b=11.2219(13)Å c=22.715(3)Å
α=90.00° β=109.948(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.38(C4H8O2)
Crystal Growth & Design (2005) 5, 3 833
a=15.937(4)Å b=11.054(3)Å c=22.206(6)Å
α=90.00° β=108.432(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.5(C6H10O),0.5(C6H12)
Crystal Growth & Design (2005) 5, 3 833
a=31.047(6)Å b=11.2665(18)Å c=22.631(4)Å
α=90.00° β=109.880(4)° γ=90.00°